It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
Avoid agitation that may affect compound stability
Complete the full 12-week protocol
However, remember that the quality of your supplement determines the quality of your results
Over time, you can spot patterns, like whether low-protein days correlate with fatigue or increased hunger, and adjust your habits accordingly
If you are still feeling unsure about where to begin, we invite you to take our Cymbiotika Expert for a personalized recommendation tailored to your specific needs
